Kibow Biotech, a developer of probiotic supplements for maintaining kidney health, announced on Friday that it has been named the recipient of The American Association of Naturopathic Physicians (AANP) Corporation of the Year Award.
Presented annually by the AANP at its Membership Meeting, the Corporation of the Year Award aims to recognise organisations whose leadership, innovation, and commitment have made significant contributions to advancing naturopathic medicine. It honours companies that demonstrate exceptional support for naturopathic physicians, patients, and the continued growth of the profession.
According to the AANP, Kibow Biotech was selected for the award based on its longstanding support of the association's mission, leadership in delivering quality products and services, commitment to innovation, and dedication to advancing the naturopathic profession.
Kibow Biotech's flagship product, Renadyl, is a scientifically formulated probiotic dietary supplement designed to help maintain healthy kidney function naturally.
BioCare climbs 1,145 places on Inc. 5000 list
DuPont recognised with R&D 100 Award for innovation in healthcare
Synaptiq Therapeutics launches and acquires clinical-stage SYN-001 programme
WuXi AppTec named to FTSE4Good Index Series for fourth consecutive year
EDX Medical to provide molecular profiling services to Astron Health
Futura Medical appoints Market Performance Group as new US distribution partner for Eroxon
MaaT Pharma to seek review after CHMP negative opinion on MaaT013 application
Sensei Biotherapeutics changes name to Faeth Therapeutics
Datavault AI and Wellgistics Health plan DelivMeds AI healthcare venture